E. Coli Nissle 1917 - Suspension for Infection Prophylaxis

NCT02802059 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

567

Enrollment

INDUSTRY

Sponsor class

Conditions

Infections

Interventions

DRUG: EcN-Suspension
DRUG: Placebo

Sponsor

Ardeypharm GmbH

Collaborators

[object Object]
[object Object]